U.S. market Open. Closes in 2 hours 14 minutes

FOLD | Amicus Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-302015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
Revenue399.36M329.23M305.51M260.89M182.24M91.25M36.93M4.96MN/A1.22M363.00K18.41M21.43M922.00K64.36M14.97M1.78MN/AN/AN/AN/A
Cost of Revenue45.20M38.60M34.47M31.04M21.96M14.40M6.24M833.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit354.16M290.63M271.05M229.84M160.27M76.84M30.69M4.12MN/AN/A363.00KN/A21.43M922.00K64.36MN/AN/AN/AN/AN/AN/A
Operating Expenses427.65M495.06M470.97M473.70M461.01M402.32M241.57M186.01M126.05M69.89M62.56M71.34M72.32M56.76M70.19M58.92M47.59MN/AN/AN/AN/A
Selling, General & Admin275.27M213.04M192.71M156.41M169.86M127.20M88.67M71.15M47.27M20.72M18.89M19.36M19.88M15.66M19.97M19.67M15.28M12.28M6.88MN/AN/A
Research & Development152.38M276.68M272.05M308.44M286.38M270.90M149.31M104.79M76.94M47.62M41.94M50.27M50.86M39.04M48.08M37.76M31.07M33.63M13.65MN/A4.43M
Other Operating Expenses-15.89M5.34M6.21M8.85M4.78M-5.63M3.59M10.07M1.83M1.55M1.72M1.71M1.58M2.06M2.13M1.49M1.24MN/AN/AN/AN/A
Operating Income-73.49M-204.43M-199.92M-243.85M-300.74M-328.78M-441.99M-181.89M-126.05M-68.66M-62.19M-52.93M-50.89M-55.84M-5.83M-43.96M-45.80M-46.86M-20.83MN/A-6.60M
Other Expenses / Income-76.61M-37.61M-41.63M-30.40M-55.17M-11.67M-7.14M-21.89M-6.07M-1.38M-952.00K901.00K2.85M-237.00K-739.00K4.60M4.64M514.36K247.27KN/A-168.00K
Before Tax Income-150.10M-242.04M-241.55M-274.25M-355.91M-349.09M-449.12M-203.78M-132.12M-70.04M-63.15M-52.03M-48.04M-56.08M-6.57M-39.35M-41.17M-46.34M-20.58MN/A-6.77M
Income Tax Expenses1.48M-5.47M8.91M2.60M478.00K-94.00K-165.12M-3.74MN/A-1.11M-3.51M-3.25M-3.63M-1.14MN/AN/AN/AN/A-611.80KN/AN/A
Net Income-151.58M-236.57M-250.46M-276.85M-356.39M-349.00M-284.00M-200.04M-132.12M-68.93M-59.63M-48.78M-44.41M-54.94M-6.57M-39.35M-41.17M-46.34M-19.97M-8.81M-6.77M
Interest Expenses50.15M37.12M32.47M22.43M18.87M22.40M17.24M5.40M1.58M1.48M46.00K89.00K148.00K260.00K278.00KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding295.16M289.06M271.42M258.87M240.42M185.79M153.36M225.85M109.92M74.44M51.29M45.57M34.57M27.73M22.62M22.49M13.24M735.97K410.22K307.54K307.54K
Diluted Shares Outstanding295.16M289.06M271.42M258.87M240.42M185.79M153.36M134.40M109.92M74.44M51.29M45.57M34.57M27.73M22.62M22.49M13.24M735.97K410.22K307.54K307.54K
EBITDA-65.62M-191.88M-196.10M-232.56M-328.97M-316.43M-428.29M-195.14M-124.21M-67.01M-61.38M-50.24M-46.31M-53.76M-4.16M-37.86M-39.93M-44.70M-19.88MN/A-6.47M
EBITDA Margin-16.43%-58.28%-64.19%-89.14%-180.52%-346.79%-1,159.73%-3,935.88%0.00%-5,474.51%-16,909.09%-272.86%-216.05%-5,830.48%-6.46%-252.97%-2,238.23%0.00%0.00%0.00%0.00%
EBIT-99.95M-204.92M-209.08M-251.83M-337.04M-326.69M-431.88M-198.38M-130.54M-68.56M-63.10M-51.94M-47.89M-55.81M-6.29M-39.35M-41.17M-46.34M-20.58M-8.81M-6.77M
EBIT Margin-25.03%-62.24%-68.44%-96.53%-184.94%-358.03%-1,169.46%-4,001.27%0.00%-5,600.90%-17,382.64%-282.12%-223.44%-6,053.69%-9.77%-262.95%-2,307.57%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-302015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙